title: [Direct costs for Parkinson's treatment in private neurology practices in Berlin].
abstract: BACKGROUND
  Aim of this study was to assess the direct costs of Parkinson's disease (PD) within a 3-month period (i.e. the accounting period for the German statutory health insurance) in 12 neurological outpatient practices in Berlin during 2006.
  
  
  METHODS
  A total of 425 patients (age 69.1+/-9.3 years, 185 females) were recruited, and sociodemographic and clinical data were obtained by a specific questionnaire. The distribution of costs was analyzed based on several clinical and patient parameters. The costs were calculated with different approaches: (1) prospectively, with the practices' accounting according to German uniform scales (GoA, EbM) and (2) retrospectively, with questionnaires for the Parkinson's patients. Costs were calculated according to current German guidelines of the statutory health insurance. Clinical parameters were assessed with a questionnaire for physicians.
  
  
  RESULTS
  The direct medical costs totaled 1,667 EUR (range 1,436-1,995 EUR, CI 95%) per patient per 3 months. Charges by physicians were 42 EUR (39-45 EUR, CI 95%) for patients with statutory health insurance and 135 EUR (106-177 EUR, CI 95%) for those with private insurance. Disease severity and disease duration correlated with higher direct medical costs. Motor fluctuations and depression also were major factors influencing cost.
  
  
  CONCLUSIONS
  Our study emphasizes the large economic burden caused mainly by PD medication and hospitalization. For the first time a direct comparison between costs and actual physicians' reimbursement was possible. In combination with further economic studies, this comparison will help to define shortcomings and excesses in PD health care services.
authors.affiliation: Neurologische Praxen, Berlin, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Ehret
authors.forename: M
authors.initials: M
authors.lastname: Balzer-Geldsetzer
authors.forename: J P
authors.initials: JP
authors.lastname: Reese
authors.forename: I
authors.initials: I
authors.lastname: Dodel
authors.forename: E
authors.initials: E
authors.lastname: Becker
authors.forename: A
authors.initials: A
authors.lastname: Christopher
authors.forename: H
authors.initials: H
authors.lastname: Friedrich
authors.forename: S
authors.initials: S
authors.lastname: Kraemer
authors.forename: W
authors.initials: W
authors.lastname: Lüer
authors.forename: M
authors.initials: M
authors.lastname: Müngersdorf
authors.forename: R
authors.initials: R
authors.lastname: Puzich
authors.forename: A
authors.initials: A
authors.lastname: Rohr
authors.forename: I
authors.initials: I
authors.lastname: Schultes-Platzek
authors.forename: V
authors.initials: V
authors.lastname: Siefjediers
authors.forename: K
authors.initials: K
authors.lastname: Tiel-Wilck
authors.forename: W H
authors.initials: WH
authors.lastname: Oertel
authors.forename: R
authors.initials: R
authors.lastname: Dodel
mesh_terms: D002947:Cities; D017281:Cost of Illness; D005260:Female; D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008875:Middle Aged; D009462:Neurology / Q000191:economics*; D010300:Parkinson Disease / Q000191:economics* / Q000453:epidemiology*; D011331:Private Practice / Q000191:economics*